speb/financial-data huggingface dataset:
ERAS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 423499000.00
ERAS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 423499000.00
ERAS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ERAS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
ERAS balance_sheet (annual, 2024-12-31) — Total Assets: 502526000.00
ERAS balance_sheet (annual, 2024-12-31) — Total Capitalization: 423499000.00
ERAS balance_sheet (annual, 2024-12-31) — Total Debt: 51889000.00
ERAS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 423499000.00
ERAS income_statement (annual, 2024-12-31) — Total Expenses: 157087000.00
ERAS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 79027000.00
ERAS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 193733000.00
ERAS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 47632000.00
ERAS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -179587000.00
ERAS income_statement (annual, 2024-12-31) — Total Unusual Items: -22500000.00
ERAS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -22500000.00
ERAS balance_sheet (annual, 2024-12-31) — Working Capital: 277398000.00
ERAS income_statement (quarterly, 2025-03-31) — +Operating Expense: 35630000.00
ERAS income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
ERAS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2262000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -10822000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1197475000.00
ERAS cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -1986000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 106492000.00
ERAS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 283260289.00
ERAS income_statement (quarterly, 2025-03-31) — Basic EPS: -0.11
ERAS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 68147000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 31525000.00
ERAS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -83000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 50811000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 28000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 70482000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 304585000.00
ERAS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 33000.00
ERAS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 34265000.00
ERAS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -31555000.00
ERAS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 1794000.00
ERAS cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -8006000.00
ERAS cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -385000.00
ERAS cash_flow (quarterly, 2025-03-31) — Change In Payable: 1794000.00
ERAS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -6212000.00
ERAS cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 459000.00
ERAS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -6138000.00
ERAS cash_flow (quarterly, 2025-03-31) — Changes In Cash: 2743000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Common Stock: 28000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 399502000.00
ERAS cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
ERAS balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 12604000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Current Assets: 314617000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 4791000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 4791000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 25471000.00
ERAS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 822000.00
ERAS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 822000.00
ERAS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 283260289.00
ERAS income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.11
ERAS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -30966000.00
ERAS income_statement (quarterly, 2025-03-31) — EBIT: -35630000.00
ERAS income_statement (quarterly, 2025-03-31) — EBITDA: -34808000.00
ERAS cash_flow (quarterly, 2025-03-31) — End Cash Position: 70890000.00
ERAS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 33000.00
ERAS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -31638000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 628000.00
ERAS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 9661000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 57934000.00
ERAS income_statement (quarterly, 2025-03-31) — Interest Income: 4740000.00
ERAS income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 4740000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 399502000.00
ERAS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 34265000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 106492000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 106492000.00
ERAS cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
ERAS balance_sheet (quarterly, 2025-03-31) — Leases: 16313000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 46020000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 46020000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 5311000.00
ERAS cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
ERAS income_statement (quarterly, 2025-03-31) — Net Income: -30966000.00
ERAS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -30966000.00
ERAS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -30966000.00
ERAS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -30966000.00
ERAS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -30966000.00
ERAS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -30966000.00
ERAS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -30966000.00
ERAS cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: 0.00
ERAS income_statement (quarterly, 2025-03-31) — Net Interest Income: 4740000.00
ERAS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 34348000.00
ERAS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 4740000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Net PPE: 47112000.00
ERAS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -83000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 399502000.00
ERAS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -34808000.00
ERAS income_statement (quarterly, 2025-03-31) — Normalized Income: -30966000.00
ERAS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -31555000.00
ERAS income_statement (quarterly, 2025-03-31) — Operating Income: -35630000.00
ERAS income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
ERAS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 283265716.00
ERAS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 10032000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 628000.00
ERAS income_statement (quarterly, 2025-03-31) — Other Gand A: 9661000.00
ERAS income_statement (quarterly, 2025-03-31) — Other Income Expense: -76000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 3023000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 251000.00
ERAS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -76000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Other Properties: 4785000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 234103000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Payables: 2262000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 14866000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 5814000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
ERAS income_statement (quarterly, 2025-03-31) — Pretax Income: -30966000.00
ERAS cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 33000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
ERAS cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: 0.00
ERAS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -10652000.00
ERAS cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -83000.00
ERAS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 822000.00
ERAS income_statement (quarterly, 2025-03-31) — Research And Development: 25969000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -798629000.00
ERAS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 45000000.00
ERAS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 9661000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Share Issued: 283265716.00
ERAS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
ERAS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 6713000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 399502000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 399502000.00
ERAS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ERAS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
ERAS balance_sheet (quarterly, 2025-03-31) — Total Assets: 471244000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 399502000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Total Debt: 50811000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 399502000.00
ERAS income_statement (quarterly, 2025-03-31) — Total Expenses: 35630000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 71742000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 156627000.00
ERAS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 46271000.00
ERAS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -35630000.00
ERAS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
ERAS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
ERAS balance_sheet (quarterly, 2025-03-31) — Working Capital: 289146000.00
ERAS income_statement (quarterly, 2025-06-30) — +Operating Expense: 30625000.00
ERAS income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
ERAS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1663000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -11462000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1204320000.00
ERAS cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -1499000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 86088000.00
ERAS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 283355730.00
ERAS income_statement (quarterly, 2025-06-30) — Basic EPS: -0.12
ERAS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 70890000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 30814000.00
ERAS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -5530000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 49423000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 28000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 66143000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 300661000.00
ERAS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 447000.00
ERAS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 15745000.00
ERAS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -20531000.00
ERAS cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -599000.00
ERAS cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 1378000.00
ERAS cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -677000.00
ERAS cash_flow (quarterly, 2025-06-30) — Change In Payable: -599000.00
ERAS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 779000.00
ERAS cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 57000.00
ERAS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 159000.00
ERAS cash_flow (quarterly, 2025-06-30) — Changes In Cash: -4339000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Common Stock: 28000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 372258000.00
ERAS cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
ERAS balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 15136000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Current Assets: 310660000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 4709000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 4709000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 28151000.00
ERAS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 787000.00
ERAS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 787000.00
ERAS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 283355730.00
ERAS income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.12
ERAS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -33876000.00
ERAS income_statement (quarterly, 2025-06-30) — EBIT: -30625000.00
ERAS income_statement (quarterly, 2025-06-30) — EBITDA: -29838000.00
ERAS cash_flow (quarterly, 2025-06-30) — End Cash Position: 66551000.00
ERAS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 447000.00
ERAS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -26061000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 415000.00
ERAS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 9455000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 57101000.00
ERAS income_statement (quarterly, 2025-06-30) — Interest Income: 4330000.00
ERAS income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 4330000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 372258000.00
ERAS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 15745000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 86088000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 86088000.00
ERAS cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
ERAS balance_sheet (quarterly, 2025-06-30) — Leases: 16313000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 44714000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 44714000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 5336000.00
ERAS cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
ERAS income_statement (quarterly, 2025-06-30) — Net Income: -33876000.00
ERAS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -33876000.00
ERAS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -33876000.00
ERAS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -33876000.00
ERAS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -33876000.00
ERAS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -33876000.00
ERAS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -33876000.00
ERAS cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -5500000.00
ERAS income_statement (quarterly, 2025-06-30) — Net Interest Income: 4330000.00
ERAS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 21275000.00
ERAS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 4330000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Net PPE: 45639000.00
ERAS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -30000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 372258000.00
ERAS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -22338000.00
ERAS income_statement (quarterly, 2025-06-30) — Normalized Income: -26376000.00
ERAS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -20531000.00
ERAS income_statement (quarterly, 2025-06-30) — Operating Income: -30625000.00
ERAS income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
ERAS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 283650139.00
ERAS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 9999000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 415000.00
ERAS income_statement (quarterly, 2025-06-30) — Other Gand A: 9455000.00
ERAS income_statement (quarterly, 2025-06-30) — Other Income Expense: -7581000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 2999000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 263000.00
ERAS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -81000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Other Properties: 4638000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 234518000.00
ERAS income_statement (quarterly, 2025-06-30) — Other Special Charges: 7500000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Payables: 1663000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 16799000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 6643000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
ERAS income_statement (quarterly, 2025-06-30) — Pretax Income: -33876000.00
ERAS cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 447000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
ERAS cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -5500000.00
ERAS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -56552000.00
ERAS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -30000.00
ERAS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 787000.00
ERAS income_statement (quarterly, 2025-06-30) — Research And Development: 21170000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -832505000.00
ERAS cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 77827000.00
ERAS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 9455000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Share Issued: 283650139.00
ERAS income_statement (quarterly, 2025-06-30) — Special Income Charges: -7500000.00
ERAS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 6398000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 372258000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 372258000.00
ERAS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ERAS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
ERAS balance_sheet (quarterly, 2025-06-30) — Total Assets: 445386000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 372258000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Total Debt: 49423000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 372258000.00
ERAS income_statement (quarterly, 2025-06-30) — Total Expenses: 30625000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 73128000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 134726000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 44977000.00
ERAS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -38125000.00
ERAS income_statement (quarterly, 2025-06-30) — Total Unusual Items: -7500000.00
ERAS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -7500000.00
ERAS balance_sheet (quarterly, 2025-06-30) — Working Capital: 282509000.00
ERAS income_statement (quarterly, 2025-09-30) — +Operating Expense: 32546000.00
ERAS income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
ERAS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 3029000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -11919000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1210326000.00
ERAS cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -1022000.00
ERAS cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
ERAS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 73982000.00
ERAS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 283681570.00
ERAS income_statement (quarterly, 2025-09-30) — Basic EPS: -0.11
ERAS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 66551000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 30081000.00
ERAS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -4006000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 48293000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 28000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 70230000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 288400000.00
ERAS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 41000.00
ERAS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 25704000.00
ERAS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -21658000.00
ERAS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 1366000.00
ERAS cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 1190000.00
ERAS cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -397000.00
ERAS cash_flow (quarterly, 2025-09-30) — Change In Payable: 1366000.00
ERAS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 2556000.00
ERAS cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -903000.00
ERAS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1256000.00
ERAS cash_flow (quarterly, 2025-09-30) — Changes In Cash: 4087000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Common Stock: 28000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 347886000.00
ERAS cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
ERAS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 11863000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Current Assets: 299925000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 4885000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 4885000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 28712000.00
ERAS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 755000.00
ERAS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 755000.00
ERAS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 283681570.00
ERAS income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.11
ERAS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -30612000.00
ERAS income_statement (quarterly, 2025-09-30) — EBIT: -32546000.00
ERAS income_statement (quarterly, 2025-09-30) — EBITDA: -31791000.00
ERAS cash_flow (quarterly, 2025-09-30) — End Cash Position: 70638000.00
ERAS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 41000.00
ERAS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -25664000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 649000.00
ERAS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 10072000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 56037000.00
ERAS income_statement (quarterly, 2025-09-30) — Interest Income: 3971000.00
ERAS income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 3971000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 347886000.00
ERAS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 25704000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 73982000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 73982000.00
ERAS cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
ERAS balance_sheet (quarterly, 2025-09-30) — Leases: 16313000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 43408000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 43408000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 5222000.00
ERAS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
ERAS income_statement (quarterly, 2025-09-30) — Net Income: -30612000.00
ERAS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -30612000.00
ERAS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -30612000.00
ERAS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -30612000.00
ERAS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -30612000.00
ERAS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -30612000.00
ERAS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -30612000.00
ERAS cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -4000000.00
ERAS income_statement (quarterly, 2025-09-30) — Net Interest Income: 3971000.00
ERAS cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 29710000.00
ERAS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 3971000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Net PPE: 44118000.00
ERAS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -6000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 347886000.00
ERAS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -29791000.00
ERAS income_statement (quarterly, 2025-09-30) — Normalized Income: -28612000.00
ERAS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -21658000.00
ERAS income_statement (quarterly, 2025-09-30) — Operating Income: -32546000.00
ERAS income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
ERAS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 283711805.00
ERAS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 11525000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 649000.00
ERAS income_statement (quarterly, 2025-09-30) — Other Gand A: 10072000.00
ERAS income_statement (quarterly, 2025-09-30) — Other Income Expense: -2037000.00
ERAS cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 2000000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 2376000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 395000.00
ERAS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -37000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Other Properties: 4421000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 218170000.00
ERAS income_statement (quarterly, 2025-09-30) — Other Special Charges: 2000000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Payables: 3029000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 14892000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 8935000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
ERAS income_statement (quarterly, 2025-09-30) — Pretax Income: -30612000.00
ERAS cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 41000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
ERAS cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -4000000.00
ERAS cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -41540000.00
ERAS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -6000.00
ERAS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 755000.00
ERAS income_statement (quarterly, 2025-09-30) — Research And Development: 22474000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -863117000.00
ERAS cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 71250000.00
ERAS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 10072000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Share Issued: 283711805.00
ERAS income_statement (quarterly, 2025-09-30) — Special Income Charges: -2000000.00
ERAS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 5965000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 347886000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 347886000.00
ERAS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ERAS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
ERAS balance_sheet (quarterly, 2025-09-30) — Total Assets: 420401000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 347886000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Total Debt: 48293000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 347886000.00
ERAS income_statement (quarterly, 2025-09-30) — Total Expenses: 32546000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 72515000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 120476000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 43803000.00
ERAS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -34546000.00
ERAS income_statement (quarterly, 2025-09-30) — Total Unusual Items: -2000000.00
ERAS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -2000000.00
ERAS balance_sheet (quarterly, 2025-09-30) — Working Capital: 271213000.00
ERAS income_statement (annual, 2025-12-31) — +Operating Expense: 131405000.00
ERAS income_statement (quarterly, 2025-12-31) — +Operating Expense: 32604000.00
ERAS income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
ERAS income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
ERAS balance_sheet (annual, 2025-12-31) — Accounts Payable: 981000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 981000.00
ERAS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -12661000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -12661000.00
ERAS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1216724000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1216724000.00
ERAS cash_flow (annual, 2025-12-31) — Amortization Of Securities: -5087000.00
ERAS cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -580000.00
ERAS cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
ERAS cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
ERAS balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 65721000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 65721000.00
ERAS income_statement (annual, 2025-12-31) — Basic Average Shares: 283533696.00
ERAS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 283829318.00
ERAS income_statement (annual, 2025-12-31) — Basic EPS: -0.44
ERAS income_statement (quarterly, 2025-12-31) — Basic EPS: -0.10
ERAS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 68147000.00
ERAS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 70638000.00
ERAS balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 29030000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 29030000.00
ERAS cash_flow (annual, 2025-12-31) — Capital Expenditure: -9628000.00
ERAS cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -9000.00
ERAS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 47139000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 47139000.00
ERAS balance_sheet (annual, 2025-12-31) — Capital Stock: 28000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 28000.00
ERAS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 73805000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 73805000.00
ERAS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 276075000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 276075000.00
ERAS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1096000.00
ERAS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 575000.00
ERAS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 100425000.00
ERAS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 24711000.00
ERAS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -95455000.00
ERAS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -21711000.00
ERAS cash_flow (annual, 2025-12-31) — Change In Account Payable: 513000.00
ERAS cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -2048000.00
ERAS cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -3768000.00
ERAS cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 1670000.00
ERAS cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -1862000.00
ERAS cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -403000.00
ERAS cash_flow (annual, 2025-12-31) — Change In Payable: 513000.00
ERAS cash_flow (quarterly, 2025-12-31) — Change In Payable: -2048000.00
ERAS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -3255000.00
ERAS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -378000.00
ERAS cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 1789000.00
ERAS cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 2176000.00
ERAS cash_flow (annual, 2025-12-31) — Change In Working Capital: -3328000.00
ERAS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1395000.00
ERAS cash_flow (annual, 2025-12-31) — Changes In Cash: 6066000.00
ERAS cash_flow (quarterly, 2025-12-31) — Changes In Cash: 3575000.00
ERAS balance_sheet (annual, 2025-12-31) — Common Stock: 28000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Common Stock: 28000.00
ERAS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 325171000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 325171000.00
ERAS cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
ERAS cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
ERAS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 10391000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 10391000.00
ERAS balance_sheet (annual, 2025-12-31) — Current Assets: 286239000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Current Assets: 286239000.00
ERAS balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 5066000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 5066000.00
ERAS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 5066000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 5066000.00
ERAS balance_sheet (annual, 2025-12-31) — Current Liabilities: 28511000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 28511000.00
ERAS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 3107000.00
ERAS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 743000.00
ERAS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 3107000.00
ERAS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 743000.00
ERAS income_statement (annual, 2025-12-31) — Diluted Average Shares: 283533696.00
ERAS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 283829318.00
ERAS income_statement (annual, 2025-12-31) — Diluted EPS: -0.44
ERAS income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.10
ERAS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -124546000.00
ERAS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -29092000.00
ERAS income_statement (annual, 2025-12-31) — EBIT: -131405000.00
ERAS income_statement (quarterly, 2025-12-31) — EBIT: -32604000.00
ERAS income_statement (annual, 2025-12-31) — EBITDA: -128298000.00
ERAS income_statement (quarterly, 2025-12-31) — EBITDA: -31861000.00
ERAS cash_flow (annual, 2025-12-31) — End Cash Position: 74213000.00
ERAS cash_flow (quarterly, 2025-12-31) — End Cash Position: 74213000.00
ERAS cash_flow (annual, 2025-12-31) — Financing Cash Flow: 1096000.00
ERAS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 575000.00
ERAS cash_flow (annual, 2025-12-31) — Free Cash Flow: -105083000.00
ERAS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -21720000.00
ERAS balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 628000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 628000.00
ERAS income_statement (annual, 2025-12-31) — General And Administrative Expense: 38551000.00
ERAS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 9363000.00
ERAS balance_sheet (annual, 2025-12-31) — Gross PPE: 54994000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 54994000.00
ERAS income_statement (annual, 2025-12-31) — Interest Income: 16607000.00
ERAS income_statement (quarterly, 2025-12-31) — Interest Income: 3566000.00
ERAS income_statement (annual, 2025-12-31) — Interest Income Non Operating: 16607000.00
ERAS income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 3566000.00
ERAS balance_sheet (annual, 2025-12-31) — Invested Capital: 325171000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 325171000.00
ERAS cash_flow (annual, 2025-12-31) — Investing Cash Flow: 100425000.00
ERAS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 24711000.00
ERAS balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 65721000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 65721000.00
ERAS balance_sheet (annual, 2025-12-31) — Investments And Advances: 65721000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 65721000.00
ERAS cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
ERAS cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
ERAS balance_sheet (annual, 2025-12-31) — Leases: 16313000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Leases: 16313000.00
ERAS balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 42073000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 42073000.00
ERAS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 42073000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 42073000.00
ERAS balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 5222000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 5222000.00
ERAS cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
ERAS cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
ERAS income_statement (annual, 2025-12-31) — Net Income: -124546000.00
ERAS income_statement (quarterly, 2025-12-31) — Net Income: -29092000.00
ERAS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -124546000.00
ERAS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -29092000.00
ERAS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -124546000.00
ERAS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -29092000.00
ERAS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -124546000.00
ERAS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -29092000.00
ERAS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -124546000.00
ERAS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -29092000.00
ERAS cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -124546000.00
ERAS cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -29092000.00
ERAS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -124546000.00
ERAS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -29092000.00
ERAS cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -9500000.00
ERAS cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: 0.00
ERAS income_statement (annual, 2025-12-31) — Net Interest Income: 16607000.00
ERAS income_statement (quarterly, 2025-12-31) — Net Interest Income: 3566000.00
ERAS cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 110053000.00
ERAS cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 24720000.00
ERAS income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 16607000.00
ERAS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 3566000.00
ERAS balance_sheet (annual, 2025-12-31) — Net PPE: 42333000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Net PPE: 42333000.00
ERAS cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -128000.00
ERAS cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -9000.00
ERAS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 325171000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 325171000.00
ERAS income_statement (annual, 2025-12-31) — Normalized EBITDA: -118798000.00
ERAS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -31861000.00
ERAS income_statement (annual, 2025-12-31) — Normalized Income: -115046000.00
ERAS income_statement (quarterly, 2025-12-31) — Normalized Income: -29092000.00
ERAS cash_flow (annual, 2025-12-31) — Operating Cash Flow: -95455000.00
ERAS cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -21711000.00
ERAS income_statement (annual, 2025-12-31) — Operating Income: -131405000.00
ERAS income_statement (quarterly, 2025-12-31) — Operating Income: -32604000.00
ERAS income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
ERAS income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
ERAS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 284159076.00
ERAS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 284159076.00
ERAS balance_sheet (annual, 2025-12-31) — Other Current Assets: 10164000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 10164000.00
ERAS balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 628000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 628000.00
ERAS income_statement (annual, 2025-12-31) — Other Gand A: 38551000.00
ERAS income_statement (quarterly, 2025-12-31) — Other Gand A: 9363000.00
ERAS income_statement (annual, 2025-12-31) — Other Income Expense: -9748000.00
ERAS income_statement (quarterly, 2025-12-31) — Other Income Expense: -54000.00
ERAS cash_flow (annual, 2025-12-31) — Other Non Cash Items: 9500000.00
ERAS cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 0.00
ERAS balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1861000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1861000.00
ERAS balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 399000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 399000.00
ERAS income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -248000.00
ERAS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -54000.00
ERAS balance_sheet (annual, 2025-12-31) — Other Properties: 4429000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Other Properties: 4429000.00
ERAS balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 202270000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 202270000.00
ERAS income_statement (annual, 2025-12-31) — Other Special Charges: 9500000.00
ERAS income_statement (quarterly, 2025-12-31) — Other Special Charges: 0.00
ERAS balance_sheet (annual, 2025-12-31) — Payables: 981000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Payables: 981000.00
ERAS balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 11372000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 11372000.00
ERAS balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 12073000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 12073000.00
ERAS balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
ERAS balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
ERAS income_statement (annual, 2025-12-31) — Pretax Income: -124546000.00
ERAS income_statement (quarterly, 2025-12-31) — Pretax Income: -29092000.00
ERAS cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 1096000.00
ERAS cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 575000.00
ERAS balance_sheet (annual, 2025-12-31) — Properties: 0.00
ERAS balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ERAS cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -9500000.00
ERAS cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: 0.00
ERAS cash_flow (annual, 2025-12-31) — Purchase Of Investment: -150974000.00
ERAS cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -42230000.00
ERAS cash_flow (annual, 2025-12-31) — Purchase Of PPE: -128000.00
ERAS cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -9000.00
ERAS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 3107000.00
ERAS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 743000.00
ERAS income_statement (annual, 2025-12-31) — Research And Development: 92854000.00
ERAS income_statement (quarterly, 2025-12-31) — Research And Development: 23241000.00
ERAS balance_sheet (annual, 2025-12-31) — Retained Earnings: -892209000.00
ERAS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -892209000.00
ERAS cash_flow (annual, 2025-12-31) — Sale Of Investment: 261027000.00